Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Taking Saw palmetto and Pygeum africana can change the levels of certain steroids in urine, which could cause confusion in doping tests.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

New genes and pathways are important for testosterone production and male sexual development.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.